Nicola De Luca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nicola De Luca has a total of 572 co-authors. Here are the top co-authors by number of shared publications:
- Bruno Trimarco
Dipartimento di Scienze Biomediche Avanzate, Università FEDERICO II, 80131 Napoli, Italy
71 shared publications - Raffaele Izzo
Department of Advanced Biomedical Sciences, “Federico II” University of Naples, 80131 Naples, Italy
36 shared publications - Massimo Volpe
Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy
32 shared publications - Giovanni de Simone
Federico II University
21 shared publications - Giuseppe Lembo
Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed , via dell’Elettronica, Pozzilli, IS 86077
21 shared publications - Alberto Cuocolo
Department of Advanced Biomedical Sciences, University of Naples “Federico II”, Naples, Italy
18 shared publications
Latest Publications
- Open Access
- 18 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 2062
Predictive Modeling of Acute Hypertensive Disorders in a Real-World Cohort: Integrating Clinical Predictors and Data-Driven Methods
Background: Acute hypertensive disorders, including hypertensive emergencies (HEs) and urgencies (HUs), are a frequent cause of emergency department (ED) visits. Early differentiation between HEs and HUs is essential, as their clinical management and prognostic implications differ substantially. Methods: We retrospectively analyzed patients admitted to an Italian second-level ED between January and June 2022 with systolic blood pressure (SBP) ≥ 180 mmHg and/or diastolic blood pressure(DBP) ≥ 110 mmHg. Patients were categorized based on the presence of acute hypertension-mediated organ damage (A-HMOD). To identify the main predictors of HEs, we applied both conventional logistic regression and machine learning approaches (Elastic Net and Random Forest). Results: Among 23,678 ED admissions, 261 patients (1.1%) had acute hypertensive disorders, of whom 115 (44%) were diagnosed with HEs and 146 (56%) with HUs. Compared with HU patients, HE patients were older and showed higher SBPand DBP at presentation, along with a greater prevalence of comorbidities such as diabetes, coronary artery disease, and chronic kidney disease (all p < 0.05). In multivariable logistic regression, troponin I levels independently predicted the occurrence of HEs (OR: 2.82; 95%CI: 1.65–4.82; p < 0.001), even after adjusting for confounders. Machine learning analyses confirmed troponin I as the most influential predictor, followed by age and SBP, with the Random Forest model achieving a high predictive performance (AUCROC: 0.93; 95%CI: 0.90–0.96). Elastic Net regression further highlighted troponin I as the most influential variable with the highest standardized coefficient (β = 4.13). As determined by the Youden index, the optimal diagnostic threshold for troponin I was 0.12 ng/mL (AUCROC: 0.66; 95%CI: 0.60–0.72). Conclusions: In patients presenting to the ED, withacute hypertensive disorders, elevated troponin I levels, older age, and higher SBP at admission may serve as early indicators of emergencies.
- 18 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 2062
Open AccessPredictive Modeling of Acute Hypertensive Disorders in a Real-World Cohort: Integrating Clinical Predictors and Data-Driven Methods
Background: Acute hypertensive disorders, including hypertensive emergencies (HEs) and urgencies (HUs), are a frequent cause of emergency department (ED) visits. Early differentiation between HEs and HUs is essential, as their clinical management and prognostic implications differ substantially. Methods: We retrospectively analyzed patients admitted to an Italian second-level ED between January and June 2022 with systolic blood pressure (SBP) ≥ 180 mmHg and/or diastolic blood pressure(DBP) ≥ 110 mmHg. Patients were categorized based on the presence of acute hypertension-mediated organ damage (A-HMOD). To identify the main predictors of HEs, we applied both conventional logistic regression and machine learning approaches (Elastic Net and Random Forest). Results: Among 23,678 ED admissions, 261 patients (1.1%) had acute hypertensive disorders, of whom 115 (44%) were diagnosed with HEs and 146 (56%) with HUs. Compared with HU patients, HE patients were older and showed higher SBPand DBP at presentation, along with a greater prevalence of comorbidities such as diabetes, coronary artery disease, and chronic kidney disease (all p < 0.05). In multivariable logistic regression, troponin I levels independently predicted the occurrence of HEs (OR: 2.82; 95%CI: 1.65–4.82; p < 0.001), even after adjusting for confounders. Machine learning analyses confirmed troponin I as the most influential predictor, followed by age and SBP, with the Random Forest model achieving a high predictive performance (AUCROC: 0.93; 95%CI: 0.90–0.96). Elastic Net regression further highlighted troponin I as the most influential variable with the highest standardized coefficient (β = 4.13). As determined by the Youden index, the optimal diagnostic threshold for troponin I was 0.12 ng/mL (AUCROC: 0.66; 95%CI: 0.60–0.72). Conclusions: In patients presenting to the ED, withacute hypertensive disorders, elevated troponin I levels, older age, and higher SBP at admission may serve as early indicators of emergencies.
- Open Access
- 30 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 2018
Predicting One-Year Mortality after Discharge Using Acute Heart Failure Score (AHFS)
Background: Acute heart failure (AHF) represents a leading cause of unscheduled hospital stays, frequent rehospitalisations, and mortality worldwide. The aim of our study was to develop a bedside prognostic tool, a multivariable predictive risk score, that is useful in daily practice, thus providing an early prognostic evaluation at admission and an accurate risk stratification after discharge in patients with AHF. Methods: This study is a subanalysis of the STADE HF study, which is a single-centre, prospective, randomised controlled trial enrolling 123 patients admitted to hospital for AHF. Here, 117 patients were included in the analysis, due to data exhaustivity. Regression analysis was performed to determine predictive variables for one-year mortality and/or rehospitalisation after discharge. Results: During the first year after discharge, 23 patients died. After modellisation, the variables considered to be of prognostic relevance in terms of mortality were (1) non-ischaemic aetiology of HF, (2) elevated creatinine levels at admission, (3) moderate/severe mitral regurgitation, and (4) prior HF hospitalisation. We designed a linear model based on these four independent predictive variables, and it showed a good ability to score and predict patient mortality with an AUC of 0.84 (95%CI: 0.76–0.92), thus denoting a high discriminative ability. A risk score equation was developed. During the first year after discharge, we observed as well that 41 patients died or were rehospitalised; hence, while searching for a model that could predict worsening health conditions (i.e., death and/or rehospitalisation), only two predictive variables were identified: non-ischaemic HF aetiology and previous HF hospitalisation (also included in the one-year mortality model). This second modellisation showed a more discrete discriminative ability with an AUC of 0.67 (95% C.I. 0.59–0.77). Conclusions: The proposed risk score and model, based on readily available predictive variables, are promising and useful tools to assess, respectively, the one-year mortality risk and the one-year mortality and/or rehospitalisations in patients hospitalised for AHF and to assist clinicians in the management of patients with HF aiming at improving their prognosis.
- 30 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 2018
Open AccessPredicting One-Year Mortality after Discharge Using Acute Heart Failure Score (AHFS)
Background: Acute heart failure (AHF) represents a leading cause of unscheduled hospital stays, frequent rehospitalisations, and mortality worldwide. The aim of our study was to develop a bedside prognostic tool, a multivariable predictive risk score, that is useful in daily practice, thus providing an early prognostic evaluation at admission and an accurate risk stratification after discharge in patients with AHF. Methods: This study is a subanalysis of the STADE HF study, which is a single-centre, prospective, randomised controlled trial enrolling 123 patients admitted to hospital for AHF. Here, 117 patients were included in the analysis, due to data exhaustivity. Regression analysis was performed to determine predictive variables for one-year mortality and/or rehospitalisation after discharge. Results: During the first year after discharge, 23 patients died. After modellisation, the variables considered to be of prognostic relevance in terms of mortality were (1) non-ischaemic aetiology of HF, (2) elevated creatinine levels at admission, (3) moderate/severe mitral regurgitation, and (4) prior HF hospitalisation. We designed a linear model based on these four independent predictive variables, and it showed a good ability to score and predict patient mortality with an AUC of 0.84 (95%CI: 0.76–0.92), thus denoting a high discriminative ability. A risk score equation was developed. During the first year after discharge, we observed as well that 41 patients died or were rehospitalised; hence, while searching for a model that could predict worsening health conditions (i.e., death and/or rehospitalisation), only two predictive variables were identified: non-ischaemic HF aetiology and previous HF hospitalisation (also included in the one-year mortality model). This second modellisation showed a more discrete discriminative ability with an AUC of 0.67 (95% C.I. 0.59–0.77). Conclusions: The proposed risk score and model, based on readily available predictive variables, are promising and useful tools to assess, respectively, the one-year mortality risk and the one-year mortality and/or rehospitalisations in patients hospitalised for AHF and to assist clinicians in the management of patients with HF aiming at improving their prognosis.
- Open Access
A Comparison of Prognostic Factors in a Large Cohort of In-Hospital and Out-of-Hospital Cardiac Arrest Patients
We investigated independent factors predicting neurological outcome and death, comparing in-hospital (IHCA) and out-of-hospital cardiac arrest (OHCA) patients. The study was conducted in the mixed 34-bed Intensive Care Department at the Hôpital Universitaire de Bruxelles (HUB), Belgium. All adult consecutive cardiac arrest (CA) survivors were included between 2004 and 2022. For all patients, demographic data, medical comorbidities, CA baseline characteristics, treatments received during Intensive Care Unit stay, in-hospital major complications, and neurological outcome at three months after CA, using the Cerebral Performance Category (CPC) scale, were collected. In the multivariable analysis, in the IHCA group (n = 540), time to return of spontaneous circulation (ROSC), older age, unwitnessed CA, higher lactate on admission, asystole as initial rhythm, a non-cardiac cause of CA, the occurrence of shock, the occurrence of acute kidney injury (AKI), and the presence of previous neurological disease and of liver cirrhosis were independent predictors of an unfavorable neurological outcome. Among patients with OHCA (n = 567), time to ROSC, older age, higher lactate level on admission, unwitnessed CA, asystole or pulseless electrical activity (PEA) as initial rhythm, the occurrence of shock, a non-cardiac cause of CA, and a previous neurological disease were independent predictors of an unfavorable neurological outcome. To conclude, in our large cohort of mixed IHCA and OHCA patients, we observed numerous factors independently associated with a poor neurological outcome, with minimal differences between the two groups, reflecting the greater vulnerability of hospitalized patients.
Open AccessA Comparison of Prognostic Factors in a Large Cohort of In-Hospital and Out-of-Hospital Cardiac Arrest Patients
We investigated independent factors predicting neurological outcome and death, comparing in-hospital (IHCA) and out-of-hospital cardiac arrest (OHCA) patients. The study was conducted in the mixed 34-bed Intensive Care Department at the Hôpital Universitaire de Bruxelles (HUB), Belgium. All adult consecutive cardiac arrest (CA) survivors were included between 2004 and 2022. For all patients, demographic data, medical comorbidities, CA baseline characteristics, treatments received during Intensive Care Unit stay, in-hospital major complications, and neurological outcome at three months after CA, using the Cerebral Performance Category (CPC) scale, were collected. In the multivariable analysis, in the IHCA group (n = 540), time to return of spontaneous circulation (ROSC), older age, unwitnessed CA, higher lactate on admission, asystole as initial rhythm, a non-cardiac cause of CA, the occurrence of shock, the occurrence of acute kidney injury (AKI), and the presence of previous neurological disease and of liver cirrhosis were independent predictors of an unfavorable neurological outcome. Among patients with OHCA (n = 567), time to ROSC, older age, higher lactate level on admission, unwitnessed CA, asystole or pulseless electrical activity (PEA) as initial rhythm, the occurrence of shock, a non-cardiac cause of CA, and a previous neurological disease were independent predictors of an unfavorable neurological outcome. To conclude, in our large cohort of mixed IHCA and OHCA patients, we observed numerous factors independently associated with a poor neurological outcome, with minimal differences between the two groups, reflecting the greater vulnerability of hospitalized patients.
- 1 January 2023
- Published by Nomos Verlag in European Company Case Law (ECCL)
- Vol. 1 (4) , 379-396
Transfer of the registered office abroad and cross-border conversion. Has Italy superseded the incorporation theory?
Das europäische Gesellschaftsrecht ist ein hoch komplexes, mehrstufiges Rechtssystem. Denn sowohl das europäisches Recht selbst, als auch seine jeweiligen nationalen Umsetzungen sind für alle Spieler in der EU unmittelbar relevant. Mit einem europaweit aufgestellten Board mit Expert/innen aus allen Mitgliedsstaaten der EU bietet die neue englischsprachige Zeitschrift ECCL – European Company Case Law den idealen europäischen Überblick. Besondere Vorteile und Inhalte: zentrale Rechtsprechung und Gesetzgebung aus allen 27 Mitgliedstaaten alle relevanten EuGH-Urteile auf einen Blick Rezeption des Gesetzes über die Europäische Mustergesellschaft (EMCA) auf nationaler Ebene alle Umsetzungsgesetze der europäischen Richtlinien aktuelle Diskussionen zum Gesellschafts-, Finanz- und Konkursrecht. Es erscheinen 4 Ausgaben pro Jahr. Zielgruppen: Privatrecht und internationales Wirtschaftsrecht, zentrale Universitäts- und Jurabibliotheken europaweit, transnational agierende Unternehmen, Syndikusanwälte, in-house councils, Unternehmensjuristen, Aufsichtsbehörden, Wirtschaftsverbände europaweit European company law is part of a highly complex, multi-level legal system. This is because both European law itself and its respective national implementations are directly relevant to all players in the EU. With a pan-European board of experts representing each member state of the EU, this new English-language journal, ECCL – European Company Case Law, offers readers a comprehensive overview of law and legislations in the EU. Special content: central case law and legislations from each of the 27 member states all relevant CJEU judgments at a glance reception of the European Model Company Act (EMCA) at a national level all transposition laws of the European Directives topical discussions on Corporate, Financial and Insolvency Law ECCL is a quarterly publication. Related Categories: Private and International Commercial Law Target Audience: University libraries and law practices in Europe, transnational companies, syndics, legal counsels, corporate lawyers, supervisory authorities, European trade associations
- 1 January 2023
- Published by Nomos Verlag in European Company Case Law (ECCL)
- Vol. 1 (4) , 379-396
Transfer of the registered office abroad and cross-border conversion. Has Italy superseded the incorporation theory?
Das europäische Gesellschaftsrecht ist ein hoch komplexes, mehrstufiges Rechtssystem. Denn sowohl das europäisches Recht selbst, als auch seine jeweiligen nationalen Umsetzungen sind für alle Spieler in der EU unmittelbar relevant. Mit einem europaweit aufgestellten Board mit Expert/innen aus allen Mitgliedsstaaten der EU bietet die neue englischsprachige Zeitschrift ECCL – European Company Case Law den idealen europäischen Überblick. Besondere Vorteile und Inhalte: zentrale Rechtsprechung und Gesetzgebung aus allen 27 Mitgliedstaaten alle relevanten EuGH-Urteile auf einen Blick Rezeption des Gesetzes über die Europäische Mustergesellschaft (EMCA) auf nationaler Ebene alle Umsetzungsgesetze der europäischen Richtlinien aktuelle Diskussionen zum Gesellschafts-, Finanz- und Konkursrecht. Es erscheinen 4 Ausgaben pro Jahr. Zielgruppen: Privatrecht und internationales Wirtschaftsrecht, zentrale Universitäts- und Jurabibliotheken europaweit, transnational agierende Unternehmen, Syndikusanwälte, in-house councils, Unternehmensjuristen, Aufsichtsbehörden, Wirtschaftsverbände europaweit European company law is part of a highly complex, multi-level legal system. This is because both European law itself and its respective national implementations are directly relevant to all players in the EU. With a pan-European board of experts representing each member state of the EU, this new English-language journal, ECCL – European Company Case Law, offers readers a comprehensive overview of law and legislations in the EU. Special content: central case law and legislations from each of the 27 member states all relevant CJEU judgments at a glance reception of the European Model Company Act (EMCA) at a national level all transposition laws of the European Directives topical discussions on Corporate, Financial and Insolvency Law ECCL is a quarterly publication. Related Categories: Private and International Commercial Law Target Audience: University libraries and law practices in Europe, transnational companies, syndics, legal counsels, corporate lawyers, supervisory authorities, European trade associations
- Open Access
- 7 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3082
Lung Ultrasound in Coronary Care Unit, an Important Diagnostic Tool for Concomitant Pneumonia
Background: In the setting of a coronary care unit (CCU), the early detection of pneumonia is of paramount important to prevent severe complications. This study was designed aiming to evaluate the diagnostic accuracy of lung ultrasound (LUS) in the detection of pneumonia and compared with chest X-ray (CXR). Method: We enrolled 110 consecutive patients admitted to the CCU of Federico II University Hospital. Each patient underwent CXR and bedside LUS on admission. The final diagnosis (pneumonia vs. no pneumonia) was established by another clinician reviewing clinical and laboratory data independent of LUS results and possibly prescribing chest contrast-enhanced CT (n = 34). Results: The mean age was 70 ± 11 years old, and 68% were males. Pneumonia was clinically diagnosed in 26 (23%) patients. LUS was positive for pneumonia in 24 patients (sensitivity 92%, specificity 81%). Chest radiography was positive for pneumonia in nine patients (sensitivity 43%, specificity 95%). Using CT scan as a reference, LUS exhibited 92% sensitivity and a specificity of 96%. In ROC curve analysis, the diagnostic accuracy of CXR and LUS for the diagnosis of pneumonia was 0.86 (95% CI 0.77–0.94), which was higher than CXR 0.68 (95% CI 0.55–0.84), p < 0.05. Conclusion: Based on the findings of the present study, the accuracy of LUS in the detection of pneumonia was significantly higher than chest X-ray with comparable sensibility to CT scan.
- 7 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3082
Open AccessLung Ultrasound in Coronary Care Unit, an Important Diagnostic Tool for Concomitant Pneumonia
Background: In the setting of a coronary care unit (CCU), the early detection of pneumonia is of paramount important to prevent severe complications. This study was designed aiming to evaluate the diagnostic accuracy of lung ultrasound (LUS) in the detection of pneumonia and compared with chest X-ray (CXR). Method: We enrolled 110 consecutive patients admitted to the CCU of Federico II University Hospital. Each patient underwent CXR and bedside LUS on admission. The final diagnosis (pneumonia vs. no pneumonia) was established by another clinician reviewing clinical and laboratory data independent of LUS results and possibly prescribing chest contrast-enhanced CT (n = 34). Results: The mean age was 70 ± 11 years old, and 68% were males. Pneumonia was clinically diagnosed in 26 (23%) patients. LUS was positive for pneumonia in 24 patients (sensitivity 92%, specificity 81%). Chest radiography was positive for pneumonia in nine patients (sensitivity 43%, specificity 95%). Using CT scan as a reference, LUS exhibited 92% sensitivity and a specificity of 96%. In ROC curve analysis, the diagnostic accuracy of CXR and LUS for the diagnosis of pneumonia was 0.86 (95% CI 0.77–0.94), which was higher than CXR 0.68 (95% CI 0.55–0.84), p < 0.05. Conclusion: Based on the findings of the present study, the accuracy of LUS in the detection of pneumonia was significantly higher than chest X-ray with comparable sensibility to CT scan.
- Open Access
- 14 October 2022
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 93 (3)
Adherence to Mediterranean diet among patients with acute cardiovascular events admitted in Cardiac Rehabilitation unit
The Mediterranean Diet plays a critical role in the prevention of primary cardiovascular disease (CVD). Actually, there is a scarcity of evidence for secondary prevention. The current study aims to assess adherence to the Mediterranean diet (MD) in patients recently admitted to the Cardiac Rehabilitation Unit following acute cardiovascular disease. Adherence to MD was assessed in 111 patients admitted to the Cardiac Rehabilitation Unit of the Federico II Hospital in Naples. The Medi-Lite score was used to assess adherence to MD. The main determinant of reduced MD compliance was assessed using Pearson’s correlation analysis and a multivariable regression model. The population had a median MD adherence score of 11 and a mean score of 10.9. The lowest possible score was 5 (indicating poor adherence), and the highest possible score was 15 (excellent adherence index). There were 3 participants with a poor score (<7), 82 with a good score (7-12), and 26 with an excellent score (³13). Lower Medi-Lite score was associated with younger age and being an active worker in a multivariate regression model (both p<0.05). Our findings show that among patients admitted to the Cardiac Rehabilitation Unit after a major CV event, young active workers have the lowest adherence to MD, requiring an individualized and multidisciplinary approach to improve their adherence to MD for secondary CV prevention.
- 14 October 2022
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 93 (3)
Open AccessAdherence to Mediterranean diet among patients with acute cardiovascular events admitted in Cardiac Rehabilitation unit
The Mediterranean Diet plays a critical role in the prevention of primary cardiovascular disease (CVD). Actually, there is a scarcity of evidence for secondary prevention. The current study aims to assess adherence to the Mediterranean diet (MD) in patients recently admitted to the Cardiac Rehabilitation Unit following acute cardiovascular disease. Adherence to MD was assessed in 111 patients admitted to the Cardiac Rehabilitation Unit of the Federico II Hospital in Naples. The Medi-Lite score was used to assess adherence to MD. The main determinant of reduced MD compliance was assessed using Pearson’s correlation analysis and a multivariable regression model. The population had a median MD adherence score of 11 and a mean score of 10.9. The lowest possible score was 5 (indicating poor adherence), and the highest possible score was 15 (excellent adherence index). There were 3 participants with a poor score (<7), 82 with a good score (7-12), and 26 with an excellent score (³13). Lower Medi-Lite score was associated with younger age and being an active worker in a multivariate regression model (both p<0.05). Our findings show that among patients admitted to the Cardiac Rehabilitation Unit after a major CV event, young active workers have the lowest adherence to MD, requiring an individualized and multidisciplinary approach to improve their adherence to MD for secondary CV prevention.
- Open Access
- 23 August 2021
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 92 (1)
Lung ultrasound: a narrative review and proposed protocol for patients admitted to Cardiac Rehabilitation Unit
Lung ultrasonography (LUS) has become in the last 10 years a technique that has reduced the need of second level diagnostic methods such as chest X-ray (CXR) and computerize tomography (CT) for the diagnostic imaging of lung and pleural space, throughout its diagnostic accuracy, radiation free, low cost, real time and bedside approach. The common use of LUS has been recently extend to cardiac and pulmonary disease even in context of Cardiac Rehabilitation Unit and it could be an additional tool for physiotherapist for the management of patients during Rehabilitation course. The authors performed a literature review in PubMed and suggested a new standardize protocol for LUS, based on guidelines and expert consensus document, for patients admitted to Cardiac Rehabilitation Unit. In this protocol, LUS should be performed in six scan each hemithorax, covering twelve imagine regions. For each scan will be noted a specific physiologic or pathological patterns. Furthermore, we suggest for each patient, the use of the Lung Ultrasound Score (LUS score) to obtain a global view of lung aeration and to monitor any changes during the hospitalization. An increase in score range indicates a more severe condition. This Lung Ultrasonography Protocol should be performed in all patients at the time of admission to Cardiac Rehabilitation Unit to monitoring the aeration of the lungs and the possible lung and/or pleura complications after a cardiac disease avoiding the use of second level surveys.
- 23 August 2021
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 92 (1)
Open AccessLung ultrasound: a narrative review and proposed protocol for patients admitted to Cardiac Rehabilitation Unit
Lung ultrasonography (LUS) has become in the last 10 years a technique that has reduced the need of second level diagnostic methods such as chest X-ray (CXR) and computerize tomography (CT) for the diagnostic imaging of lung and pleural space, throughout its diagnostic accuracy, radiation free, low cost, real time and bedside approach. The common use of LUS has been recently extend to cardiac and pulmonary disease even in context of Cardiac Rehabilitation Unit and it could be an additional tool for physiotherapist for the management of patients during Rehabilitation course. The authors performed a literature review in PubMed and suggested a new standardize protocol for LUS, based on guidelines and expert consensus document, for patients admitted to Cardiac Rehabilitation Unit. In this protocol, LUS should be performed in six scan each hemithorax, covering twelve imagine regions. For each scan will be noted a specific physiologic or pathological patterns. Furthermore, we suggest for each patient, the use of the Lung Ultrasound Score (LUS score) to obtain a global view of lung aeration and to monitor any changes during the hospitalization. An increase in score range indicates a more severe condition. This Lung Ultrasonography Protocol should be performed in all patients at the time of admission to Cardiac Rehabilitation Unit to monitoring the aeration of the lungs and the possible lung and/or pleura complications after a cardiac disease avoiding the use of second level surveys.
- 28 May 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (11) , 3379-3389
Anorexia nervosa–related cardiopathy in children with physical instability: prevalence, echocardiographic characteristics and reversibility at mid-term follow-up
Prompt detection of cardiovascular abnormalities in children with anorexia nervosa and physical instability requiring hospitalization is essential to identify patients at higher cardiovascular risk. We studied all anorexia nervosa children requiring admission at Paediatric Institute in the period 2015–2019. Anorexia nervosa cardiopathy at admission was defined by the presence of at least two of the following clinical findings: pericardial effusion, mitral regurgitation, bradycardia, mitral billowing, aortic regurgitation, altered LV morphology and ECG abnormalities. Echocardiographic data were compared with those registered at 3–8-month follow-up and with data from a healthy population. Thirty-eight anorexia nervosa children were examined. Prevalence of anorexia nervosa cardiopathy at admission was 63% (24 patients). Pericardial effusion, bradycardia and mitral regurgitation were present together in 26% of patients. Most cardiovascular changes recovered at follow-up. Anorexia nervosa cardiopathy was associated with significantly lower left ventricle end-diastolic diameters and mass, and higher E wave, E/A and E/e′ ratios and left ventricle sphericity index values vs healthy population and vs anorexia nervosa children without cardiopathy (pConclusion: Among anorexia nervosa children requiring hospitalization, those presenting several cardiac findings together express an acute anorexia nervosa cardiopathy which is characterized by worse LV filling, geometry and subclinical myocardial deformation impairment. Despite treatment, in those patients, some alterations persist at mid-term follow-up. What is Known: • Cardiac and electrocardiographic changes are present in anorexia nervosa children at diagnosis or during stable disease, and most recover after body-weight treatment. • It is unknown if anorexia nervosa children with more severe cardiac impairment during hospitalization present higher cardiovascular-risk profile despite treatment. What is New: • In anorexia nervosa children needing hospitalization for physical reasons, prevalence of acute anorexia nervosa cardiopathy at admission is high, around 60%. • By advanced echocardiography, children with anorexia nervosa cardiopathy at admission have a worse cardiac filling, impaired cardiac geometry and systolic deformation that only partially recover at mid-term follow-up.
- 28 May 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (11) , 3379-3389
Anorexia nervosa–related cardiopathy in children with physical instability: prevalence, echocardiographic characteristics and reversibility at mid-term follow-up
Prompt detection of cardiovascular abnormalities in children with anorexia nervosa and physical instability requiring hospitalization is essential to identify patients at higher cardiovascular risk. We studied all anorexia nervosa children requiring admission at Paediatric Institute in the period 2015–2019. Anorexia nervosa cardiopathy at admission was defined by the presence of at least two of the following clinical findings: pericardial effusion, mitral regurgitation, bradycardia, mitral billowing, aortic regurgitation, altered LV morphology and ECG abnormalities. Echocardiographic data were compared with those registered at 3–8-month follow-up and with data from a healthy population. Thirty-eight anorexia nervosa children were examined. Prevalence of anorexia nervosa cardiopathy at admission was 63% (24 patients). Pericardial effusion, bradycardia and mitral regurgitation were present together in 26% of patients. Most cardiovascular changes recovered at follow-up. Anorexia nervosa cardiopathy was associated with significantly lower left ventricle end-diastolic diameters and mass, and higher E wave, E/A and E/e′ ratios and left ventricle sphericity index values vs healthy population and vs anorexia nervosa children without cardiopathy (pConclusion: Among anorexia nervosa children requiring hospitalization, those presenting several cardiac findings together express an acute anorexia nervosa cardiopathy which is characterized by worse LV filling, geometry and subclinical myocardial deformation impairment. Despite treatment, in those patients, some alterations persist at mid-term follow-up. What is Known: • Cardiac and electrocardiographic changes are present in anorexia nervosa children at diagnosis or during stable disease, and most recover after body-weight treatment. • It is unknown if anorexia nervosa children with more severe cardiac impairment during hospitalization present higher cardiovascular-risk profile despite treatment. What is New: • In anorexia nervosa children needing hospitalization for physical reasons, prevalence of acute anorexia nervosa cardiopathy at admission is high, around 60%. • By advanced echocardiography, children with anorexia nervosa cardiopathy at admission have a worse cardiac filling, impaired cardiac geometry and systolic deformation that only partially recover at mid-term follow-up.
- 15 April 2021
- Published by Cambridge University Press (CUP)
- p. 139-161
The Setting Up of a New Company
Taking a text, cases and materials approach, de Luca's successful textbook remains the only offering for students of European company law, and has been thoroughly updated in this new edition. Chapters have been expanded to cover the latest legislation and directives on cross-border mergers, the use of digital tools, and cross-border insolvency, while figures and graphs have been introduced to help illustrate complex processes and relationships. Clearly differentiated explanatory textboxes from the first edition have been revised, and allow students to quickly identify sources such as EU legislation, official documents and excerpts from scholarly papers. The book explores a diverse range of topics, from what European company law is, to the structure of the Societas Europaea Statute, capital markets and takeover law. It continues to be an essential resource for the growing number of graduate courses in European company law, European business law, and comparative corporate law.
- 15 April 2021
- Published by Cambridge University Press (CUP)
- p. 139-161
The Setting Up of a New Company
Taking a text, cases and materials approach, de Luca's successful textbook remains the only offering for students of European company law, and has been thoroughly updated in this new edition. Chapters have been expanded to cover the latest legislation and directives on cross-border mergers, the use of digital tools, and cross-border insolvency, while figures and graphs have been introduced to help illustrate complex processes and relationships. Clearly differentiated explanatory textboxes from the first edition have been revised, and allow students to quickly identify sources such as EU legislation, official documents and excerpts from scholarly papers. The book explores a diverse range of topics, from what European company law is, to the structure of the Societas Europaea Statute, capital markets and takeover law. It continues to be an essential resource for the growing number of graduate courses in European company law, European business law, and comparative corporate law.
- 15 April 2021
- Published by Cambridge University Press (CUP)
Preface
Taking a text, cases and materials approach, de Luca's successful textbook remains the only offering for students of European company law, and has been thoroughly updated in this new edition. Chapters have been expanded to cover the latest legislation and directives on cross-border mergers, the use of digital tools, and cross-border insolvency, while figures and graphs have been introduced to help illustrate complex processes and relationships. Clearly differentiated explanatory textboxes from the first edition have been revised, and allow students to quickly identify sources such as EU legislation, official documents and excerpts from scholarly papers. The book explores a diverse range of topics, from what European company law is, to the structure of the Societas Europaea Statute, capital markets and takeover law. It continues to be an essential resource for the growing number of graduate courses in European company law, European business law, and comparative corporate law.
- 15 April 2021
- Published by Cambridge University Press (CUP)
Preface
Taking a text, cases and materials approach, de Luca's successful textbook remains the only offering for students of European company law, and has been thoroughly updated in this new edition. Chapters have been expanded to cover the latest legislation and directives on cross-border mergers, the use of digital tools, and cross-border insolvency, while figures and graphs have been introduced to help illustrate complex processes and relationships. Clearly differentiated explanatory textboxes from the first edition have been revised, and allow students to quickly identify sources such as EU legislation, official documents and excerpts from scholarly papers. The book explores a diverse range of topics, from what European company law is, to the structure of the Societas Europaea Statute, capital markets and takeover law. It continues to be an essential resource for the growing number of graduate courses in European company law, European business law, and comparative corporate law.